Literature DB >> 31099984

KCNJ6 variants modulate reward-related brain processes and impact executive functions in attention-deficit/hyperactivity disorder.

Georg C Ziegler1, Christoph Röser1, Tobias Renner2, Tim Hahn3, Ann-Christine Ehlis4, Heike Weber1, Astrid Dempfle5, Susanne Walitza6, Christian Jacob1,7, Marcel Romanos8, Andreas J Fallgatter4, Andreas Reif1,9, Klaus-Peter Lesch1,10,11.   

Abstract

KCNJ6, encoding a potassium channel subunit, regulates the excitability of dopaminergic neurons and is expressed in attention-deficit/hyperactivity disorder (ADHD)-relevant brain regions. As a potential ADHD risk gene, KCNJ6, therefore, may contribute to the endophenotypic variation of the disorder. The impact of two SNPs, rs7275707 and rs6517442, both located in the transcriptional control region of KCNJ6, on reporter gene expression was explored in cultured cells. The KCNJ6 variants were then tested for association with ADHD and personality traits in a family-based sample (165 affected children) and an adult case-control sample (450 patients, 426 controls). Furthermore, the genotypic influence on performance in an n-back task and a cued continuous performance test (cCPT) was investigated by electroencephalography recordings. Finally, rs6517442 function was assessed by a reward anticipation paradigm using functional magnetic resonance imaging. Different haplotypes of rs7275707 and rs6517442 significantly influenced KCNJ6 gene expression proving their functional relevance on the molecular level. In the family-based children sample rs7275707 was associated with ADHD (p = .038). Moreover, rs7275707 showed association with the personality trait of Reward Dependence (p = .031). In the ADHD group, both rs7275707 and rs6517442 influenced the Go-centroid location in the cCPT and the N200 amplitude in the n-back task. Furthermore, ventral striatal activation was impacted by rs6517442 during reward anticipation. Our data indicate that functional variants of KCNJ6 influence brain activity during reward-related and executive processes supporting the view of a differential, age-dependent modulatory impact of dopamine-related brain processes in ADHD risk.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADHD; KCNJ6; dopamine; executive functions; reward

Mesh:

Substances:

Year:  2019        PMID: 31099984     DOI: 10.1002/ajmg.b.32734

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

Review 1.  Neuronal G protein-gated K+ channels.

Authors:  Haichang Luo; Ezequiel Marron Fernandez de Velasco; Kevin Wickman
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-15       Impact factor: 5.282

2.  Molecular rhythm alterations in prefrontal cortex and nucleus accumbens associated with opioid use disorder.

Authors:  Xiangning Xue; Wei Zong; Jill R Glausier; Sam-Moon Kim; Micah A Shelton; BaDoi N Phan; Chaitanya Srinivasan; Andreas R Pfenning; George C Tseng; David A Lewis; Marianne L Seney; Ryan W Logan
Journal:  Transl Psychiatry       Date:  2022-03-26       Impact factor: 7.989

Review 3.  Enhanced GIRK2 channel signaling in Down syndrome: A feasible role in the development of abnormal nascent neural circuits.

Authors:  Alexander M Kleschevnikov
Journal:  Front Genet       Date:  2022-09-12       Impact factor: 4.772

4.  Sex differences in electrophysiological properties and voltage-gated ion channel expression in the paraventricular thalamic nucleus following repeated stress.

Authors:  Brian F Corbett; Kimberly Urban; Sandra Luz; Jason Yan; Jay Arner; Seema Bhatnagar
Journal:  Biol Sex Differ       Date:  2022-09-27       Impact factor: 8.811

5.  A Common CDH13 Variant Is Associated with Low Agreeableness and Neural Responses to Working Memory Tasks in ADHD.

Authors:  Georg C Ziegler; Ann-Christine Ehlis; Heike Weber; Maria Rosaria Vitale; Johanna E M Zöller; Hsing-Ping Ku; Miriam A Schiele; Laura I Kürbitz; Marcel Romanos; Paul Pauli; Raffael Kalisch; Peter Zwanzger; Katharina Domschke; Andreas J Fallgatter; Andreas Reif; Klaus-Peter Lesch
Journal:  Genes (Basel)       Date:  2021-08-29       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.